¬üFDA³Ì·s³ø§i¡G¤â¾÷¿ç®g»PÀù¯g¨SÃöÁp
¡i©ú³ø±M°T¡j¬ü°ê¹«~©MÃĪ«ºÞ²z§½(Food and Drug Administration¡A FDA)ªº¤@¥÷³Ì·s³ø§i¦^ÅU¤F11¦~¨Óµoªíªº¬ÛÃö¬ì¾Ç¬ã¨s¡A¤´°í«ù»{¬°¼ÉÅS©ó¤â¾÷®gÀW¿ç®g¤U¤£·|¹ï°·±d³y¦¨©úÅã¦M®`¡C
³ø§iºÙ¡G¡u²{¦³ªº¬y¦æ¯f¾Ç©MÀù¯gµo¯f²v¼Æ¾ÚÄ~Äò¤ä«ù¸Ó¾÷ºc¤§«eªº¨M©w¡A§Y¦b¤â¾÷¼ÉÅSȩΧC©óȪº±¡ªp¤U¡A±µÄ²¤â¾÷¤£·|¹ï¤HÅé³y¦¨¥i¶q¤Æªº¤£¨}°·±d¼vÅT¡C¡v
³o¤@µo²{¥¿¦n»P¤U¤@¥N5G³q«Hºôµ¸ªº¥þ²yÂX±i¤£¿Ñ¦Ó¦X¡A«áªÌ«·s³ê¿ô¤F¼Æ¤Q¦~¨Ó¤H̹ï®gÀW¿ç®g¹ï°·±dºc¦¨«Â¯Ùªº¾á¼~¡C³ø§i§ó·s¤F2018¦~ªº¤@¶µÃþ¦üµo²{¡AºÙ¨S¦³½TÆwªºÃÒ¾Ú¤ä«ù¡u¤â¾÷®gÀW¿ç®g·|¤Þ°_¸~½F©ÎÀù¯g¡vªº¾á¼~¡C
³ø§i¨Ã¨S¦³µ¹¥X¦Ê¤À¤§¦Êªºµ²½×¡C¨Æ¹ê¤W¡AFDAÄ~Äò´°«P¬ã¨s¤Hû´N¤â¾÷¹ï¤HÃþªº¼vÅTÄ~Äò¶i¦æ¬ã¨s¡A¨Ã±N¬ã¨s«ÂI±q´¶³q¤HŽÄÂà¦V¨ì©ö±w¸~½Fªº¤HŽÄ¤¤¡C
¬ü°ê°ê®a¬r²z¾Ç¶µ¥Ø2018µoªíªº¤@¶µ¬ã¨sªí©ú¡A¼ÉÅS©ó«D±`°ª¤ô¥¹qºÏ¿ç®gªº¦Ñ¹«·|¾ÉP¸~½F¥Í¦¨¡C¦ý¬OFDAªº³o¤@³Ì·s³ø§i«ü¥X¤F³o¶µ¬ã¨sªº¯Ê³´¡AºÙ³o¤@µo²{¤´¬O¤£½T©wªº¡A¤£¾A¥Î©ó¤HÃþ¡C
¥Ñ©ó¾á¤ß¤â¾÷¿ç®g¡A¦b·ç¤h¨UÛµ¥¦aªº5Gºôµ¸ÂX±i¾D¨ì¤F±j¯P¤Ï¹ï¡A¨ºùتº§ø²ø¸T¤î¦w¸Ë·sªº5G²¾°Ê°ò¯¸¡AÀÀij¤¤ªº5Gºôµ¸»Ýn¤ñ4Gºôµ¸§ó¦hªº°ò¯¸¡A³o¨Ç°ò¯¸»Ýn§ó¾aªñ¥Î¤á¡A¨Ò¦p¦b¿O¬W©M«Ø¿vª«ªº°¼±¡C
¬ü°ê¥Dn²¾°Ê¹BÀç°ÓVerizon¡BAT&T¡BT-Mobile©MSprintµ¥¤~èè¶}©l«Ø³]©Mû£¥Î¨ä5Gºôµ¸¡C
¬ü°ê³¡¤À¦a°Ïªº¤Ï¹ïÁn®ö¤´¦bÄ~Äò¡A¤ñ¦p¥[¦{ªº¦Ìº¸¨¦(Mill Valley)¡C¥L̤@ª½¦b¤Ï¹ïÁp¨¹¬F©²ªº5Gºôµ¸«Ø³]¡C¬ü°êÁp¨¹³q«H©eû·|(Federal Communications Commission)¥D®uAjit Pai±N5G«Ø³]¦C¬°°ê®a«ÂI¡AºÙ¦a¤è¬F©²¹ï¤â¾÷ºôµ¸«Ø³]ªº«ÊÂê±¹¬I¬O¹Hªkªº¡C